Abstract:The high performance and increased tumor-targeting accumulation of magnetic nanocrystals (MNCs) are the most important considerations in cancer targeted magnetic hyperthermia (TMH). To achieve these goals, our study was firstly done using well-established fluorescence/magnetic Mn-Zn ferrite MNCs (core size: 14 nm) as multi-modal imaging contrast agents and highly-efficient "heat generators", which were coated with a biocompatible PEG-phospholipid (DSPE-PEG2000) and further modified by a cyclic tripeptide of arginine-glycine-aspartic acid (RGD). By using a mouse model bearing breast carcinoma (4T1), we then systematically compared PEGylated MNCs (MNCs@PEG)- and RGD-PEGylated MNCs (MNCs@RGD)-mediated tumor targeting abilities by intravenous administration. The MNCs@PEG-based passive targeting could successfully accumulate at the tumor due to the enhanced permeability and retention (EPR) effects, but the non-targeted localization might make the MNCs@PEG "leaking" from larger pores of tumor fenestrated vascular networks. Our designed MNCs@RGD, simultaneously functionalized with PEG and RGD ligands, might promote a synergistic effect including efficient tumor vasculature active targeting and EPR-mediated passive targeting, improving total MNC concentration and retention time in tumor tissues. By combining fluorescence/magnetic resonance (MR)/thermal multi-modal imaging-guided diagnostics and continuous TMH treatment under an alternating current magnetic field (ACMF, 2.58 kA m(-1), 390 kHz), the tumor surface could be heated to approximately 43-44 °C based on the MNC-mediated repeated injections. Sufficient temperature elevation induced the apoptosis of tumor cells, and inhibited the tumor angiogenesis. Compared with MNCs@PEG, the active MNCs@RGD-based tumor targeting MR image was significantly more efficient due to both the higher and long-lasting tumor accumulation, but its antitumor efficacy was not obviously improved in the TMH treatments. To achieve a singularly promising tumor TMH therapy, a greatly increased MNC content in tumor was needed. This insight indicated that not only the tumor vasculature targeting, but also the active tumor cells targeting of MNCs should receive considerable attention in future clinical TMH therapy application.

Biocompatible Magnetic Hydroxyapatite Fe3O4-HAp Nanocomposites for T1-magnetic Resonance Imaging Guided Photothermal Therapy of Breast Cancer

ROS-responsive Chlorin E6 and Silk Fibroin Loaded Ultrathin Magnetic Hydroxyapatite Nanorods for T1-magnetic Resonance Imaging Guided Photodynamic Therapy in Vitro

Facile synthesis of metformin loaded Mn3O4-HAp magnetic hydroxyapatite nanocomposites for T1-magnetic resonance imaging guided targeted chemo-phototherapy in vitro

Facile Synthesis of Multifunctional Magnetoplasmonic Au-MnO Hybrid Nanocomposites for Cancer Theranostics.

Facile synthesis of Manganese-Hafnium nanocomposites for Multimodal MRI/CT Imaging and in vitro photodynamic therapy of colon cancer

Synthesis of Biocompatible Fe3O4–TiO2 Janus Nanocomposites for T2 Magnetic Resonance Imaging and Photodynamic Therapy of Cancer in Vitro

Biodegradable manganese-doped hydroxyapatite antitumor adjuvant as a promising photo-therapeutic for cancer treatment

pH-responsive Magnetic Nanocarriers for Chelator-free Bimodal (MRI/SPECT-CT) Image Guided Chemo-hyperthermia Therapy in Human Breast Carcinoma

A biocompatible theranostic agent based on stable bismuth nanoparticles for X-ray computed tomography/magnetic resonance imaging-guided enhanced chemo/photothermal/chemodynamic therapy for tumours

Synthesis and Application of Multifunctional Magnetic Mesoporous Nanomaterials with Redox Reaction and NIR Response in Tumor Treatment

Holmium (III)-doped multifunctional nanotheranostic agent for ultra-high-field magnetic resonance imaging-guided chemo-photothermal tumor therapy

A theranostic nanocomposite system based on radial mesoporous silica hybridized with Fe3O4 nanoparticles for targeted magnetic field responsive chemotherapy of breast cancer

Gold nanoshelled liquid perfluorocarbon magnetic nanocapsules: a nanotheranostic platform for bimodal ultrasound/magnetic resonance imaging guided photothermal tumor ablation.

Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy

Drug-Loaded Magnetic Microhydrogel As Microwave Susceptible Agents for Cancer Multimodality Treatment and MR Imaging.

Synthesis of Multi-Stimuli Responsive Fe3O4 Coated with Diamonds Nanocomposite for Magnetic Assisted Chemo-Photothermal Therapy

Multi-modal Mn-Zn Ferrite Nanocrystals for Magnetically-Induced Cancer Targeted Hyperthermia: a Comparison of Passive and Active Targeting Effects.

Biocompatible Mesoporous Silica–Polydopamine Nanocomplexes as MR/Fluorescence Imaging Agent for Light-Activated Photothermal–Photodynamic Cancer Therapy In Vivo

Injectable thermosensitive magnetic nanoemulsion hydrogel for multimodal-imaging-guided accurate thermoablative cancer therapy.

Activatable Near Infrared Dye Conjugated Hyaluronic Acid Based Nanoparticles As a Targeted Theranostic Agent for Enhanced Fluorescence/ct/photoacoustic Imaging Guided Photothermal Therapy

Biomineralized Gd/Dy Composite Nanoparticles for Enhanced Tumor Photoablation with Precise T/T-MR/CT/thermal Imaging Guidance